[HTML][HTML] The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events …

FJ Enguita, AL Leitão, JT McDonald, V Zaksas… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Viral infections are complex processes based on an intricate network of
molecular interactions. The infectious agent hijacks components of the cellular machinery for …

SARS-CoV-2 and atherosclerosis: should COVID-19 be recognized as a new predisposing cardiovascular risk factor?

M Vinciguerra, S Romiti, GM Sangiorgi, D Rose… - Journal of …, 2021 - mdpi.com
At the beginning of the COVID-19 pandemic, the lung was recognized as the main target
organ; now, new evidence suggests that SARS-CoV-2 infection leads to vascular disease. In …

Targeting the pentose phosphate pathway for SARS-CoV-2 therapy

D Bojkova, R Costa, P Reus, M Bechtel, MC Jaboreck… - Metabolites, 2021 - mdpi.com
SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which
effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of the host cell …

Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?

J Zhang, H Zhang, L Sun - MAbs, 2022 - Taylor & Francis
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …

A comparative study of the plasma chemokine profile in COVID-19 patients infected with different SARS-CoV-2 variants

ZR Korobova, NA Arsentieva, NE Liubimova… - International Journal of …, 2022 - mdpi.com
Background. Infection caused by SARS-CoV-2 mostly affects the upper and lower
respiratory tracts and causes symptoms ranging from the common cold to pneumonia with …

[HTML][HTML] In silico drug repurposing in COVID-19: A network-based analysis

P Sibilio, S Bini, G Fiscon, M Sponziello, F Conte… - Biomedicine & …, 2021 - Elsevier
The SARS-CoV-2 pandemic is a worldwide public health emergency. Despite the beginning
of a vaccination campaign, the search for new drugs to appropriately treat COVID-19 …

[HTML][HTML] Biochanin A as a modulator of the inflammatory response: an updated overview and therapeutic potential

FB Felix, JP Vago, VA Beltrami, JMD Araujo… - Pharmacological …, 2022 - Elsevier
Uncontrolled inflammation and failure to resolve the inflammatory response are crucial
factors involved in the progress of inflammatory diseases. Current therapeutic strategies …

Vaccination hesitancy and the “myth” on mRNA‐based vaccines in Italy in the COVID‐19 era: Does urgency meet major safety criteria?

S Chirumbolo - Journal of Medical Virology, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) vaccination campaign in Italy has started
with a huge perplexity about vaccine efficacy, vaccine‐borne adverse effects and vaccine …

Comparing the cytokine storms of COVID-19 and pandemic influenza

LM Pacheco-Hernández… - Journal of interferon & …, 2022 - liebertpub.com
Emerging respiratory viruses are major health threats due to their potential to cause massive
outbreaks. Over the past 2 years, the coronavirus disease 2019 (COVID-19) pandemic has …

Immunopathogenesis and immunogenetic variants in COVID-19

P Sagulkoo, K Plaimas, A Suratanee… - Current …, 2022 - ingentaconnect.com
Coronavirus disease 2019 (COVID-19) continues to spread globally despite the discovery of
vaccines. Many people die due to COVID-19 as a result of catastrophic consequences, such …